Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Physiology

Yokohama City University School of Medicine

Yokohama 236-0004

Japan

Name/email consistency: high

Department of Physiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan. 2004 - 2006
Department of Pediatric Cardiology, Institute of Advanced Biomedical Engineering and Science, Graduate School of Medicine, Tokyo Women's Medical University, Japan. 2003
Department of Pediatric Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, 8-1 Kawada-cho, Japan. 2003

Post-transcriptional downregulation of sarcolipin mRNA by triiodothyronine in the atrial myocardium. Minamisawa, S., Uemura, N., Sato, Y., Yokoyama, U., Yamaguchi, T., Inoue, K., Nakagome, M., Bai, Y., Hori, H., Shimizu, M., Mochizuki, S., Ishikawa, Y. FEBS Lett. (2006) [Pubmed]
Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias. Minamisawa, S., Sato, Y., Cho, M.C. Exp. Mol. Med. (2004) [Pubmed]
Junctophilin type 2 is associated with caveolin-3 and is down-regulated in the hypertrophic and dilated cardiomyopathies. Minamisawa, S., Oshikawa, J., Takeshima, H., Hoshijima, M., Wang, Y., Chien, K.R., Ishikawa, Y., Matsuoka, R. Biochem. Biophys. Res. Commun. (2004) [Pubmed]
Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. Minamisawa, S., Wang, Y., Chen, J., Ishikawa, Y., Chien, K.R., Matsuoka, R. J. Biol. Chem. (2003) [Pubmed]
Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Minamisawa, S., Sato, Y., Tatsuguchi, Y., Fujino, T., Imamura, S., Uetsuka, Y., Nakazawa, M., Matsuoka, R. Biochem. Biophys. Res. Commun. (2003) [Pubmed]